Both in Pharmaceuticals
Rallybio vs Genelux
Over the past year RLYB returned +196.7% and GNLX returned −76.7%; their daily moves had a correlation of 0.07.
RLYB +196.7% GNLX −76.7%Growth of $1, one year, split-adjusted
| Metric | RLYB | GNLX |
|---|---|---|
| Price | $15.86 | $1.92 |
| Market cap | $85.4M | $86.9M |
| Today | +0.63% | −4.00% |
| 1 month | −6.2% | −26.2% |
| 6 months | +11.1% | −30.7% |
| Year to date | +189.0% | −56.0% |
| 1 year | +184.3% | −76.2% |
| Revenue growth (YoY) | −100.0% | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | 3.2× | — |
| Price / sales | 196.7× | 10,858.9× |
| Net cash | $90.7M | $18.7M |
| Dividend yield | — | — |
| Volatility (60d) | 23.9% | 65.8% |
| Short % of float | 1.6% | 12.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).